arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

DYADIC INTERNATIONAL INC

DYAI
$0.41 ▼ -0.01 (-2.81%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
36 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

DYADIC INTERNATIONAL INC faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth -0.6%
Op. Margin -213.7%
ROIC 68.0%
FCF / Share None
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

36-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$961.14K
↓ -0.6%
Net Income Profit after all expenses
$-1.95M
↑ +3.6%
Operating Margin Operating profit as % of sales
-213.7%
↓ -24.8% 0th
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
1
Financial Health
25
Cash Quality
52

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 10 years · 36 quarters